Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
HY Hyster-Yale Materials Handling Inc
CM Canadian Imperial Bank of Commerce
SFRFF Silver Fields Resources Inc
BAC Bank of America Corp
CHKJQ Chesapeake Energy Corp
ESPR Esperion Therapeutics Inc
AMZN Amazon.com Inc
VEEV Veeva Systems Inc
AVGO Broadcom Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Closing Price
$148.10
Day's Change
-2.16 (-1.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
151.58
Day's Low
147.90
Volume
(Light)
Volume:
2,427,522

10-day average volume:
4,062,678
2,427,522
Latest Earnings Beat Consensus (Q2 ending 06/2020)Next Earnings Announcement
Q2
Announced July 30, 2020
$1.89Q2 Consensus
of 12 analysts
$1.56Difference from
consensus
17.35%
Q3 Earnings
will announce
(Unconfirmed) October 27, 2020

Quarterly Earnings History and Estimates

Show high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

Display:

UpdateCancel

LLY's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.